These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 20848856

  • 1. [Development of new methods for the diagnosis of nasopharyngeal carcinoma].
    Pi GH, Cheng DS, Zhou Y, Zhang WL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):65-7. PubMed ID: 20848856
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of detection of Epstein-Barr virus Rta/IgG in nasopharyngeal carcinoma].
    Zheng YM, Cain YL, Cheng JR, Li J, Mo YK, Gao JQ, Dong ZR, Zhong QY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):285-7. PubMed ID: 20108775
    [Abstract] [Full Text] [Related]

  • 3. [Expression, purification and diagnostic application of EBV TK kinase].
    Huang B, Li B, Zhou W, Pi G, Tang W, Gu S.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):184-6. PubMed ID: 12196837
    [Abstract] [Full Text] [Related]

  • 4. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 5. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of combined determinations of Epstein-Barr virus antibodies for nasopharyngeal carcinoma assessed with receiver operating characteristic curve based on logistic regression].
    Cai YL, Zheng YM, Cheng JR, Li J, Mo YK, Zhong QY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):384-7. PubMed ID: 20387494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma.
    Zhang C, Zong Y, Huang B, Sun Y, Ye Y, Feng K, Li J, Zhang F.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):356-9. PubMed ID: 12408763
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 11. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
    Wan Z, Pi G, Sun N.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179
    [Abstract] [Full Text] [Related]

  • 12. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH, Soo MY, Gan YY, Fones-Tan A, Sim PS, Kaur A, Chew CT.
    Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815
    [Abstract] [Full Text] [Related]

  • 13. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, Zong YS, Ng MH.
    Int J Cancer; 2003 Jul 10; 105(5):706-9. PubMed ID: 12740922
    [Abstract] [Full Text] [Related]

  • 14. [The purification and application of Epstein-Barr virus gp125].
    Wang G, Pi G, Gu S.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun 10; 12(2):143-6. PubMed ID: 12515193
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G, Bitzer M, Bross KJ, Brugger W, Boldt C, Hirsch FW, Weitzmann U, Löhr GW.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1837-43. PubMed ID: 6094138
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
    Liu MY, Chang YL, Ma J, Yang HL, Hsu MM, Chen CJ, Chen JY, Yang CS.
    J Med Virol; 1997 Jul 30; 52(3):262-9. PubMed ID: 9210034
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma.
    Chang C, Middeldorp J, Yu KJ, Juwana H, Hsu WL, Lou PJ, Wang CP, Chen JY, Liu MY, Pfeiffer RM, Chen CJ, Hildesheim A.
    J Med Virol; 2013 Mar 30; 85(3):524-9. PubMed ID: 23280934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.